CD2 rescues T cells from T-cell receptor/CD3 apoptosis: A role for the Fas/Fas-L system

Blood

Volumn 89, Issue 10, 1997, Pages 3717-3726

  Ayroldi, Emira ^a   Migliorati, Graziella ^a   Cannarile, Lorenza ^a   Moraca, Rosalba ^a   Delfino, Domenico V ^a   Riccardi, Carlo ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b P ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STIMULATION; CELL SURVIVAL; LYMPHOID CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; THYMOCYTE; VIRUS CELL TRANSFORMATION;

EID: 0030926975     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3717.3717_3717_3726     Document Type: Article

References (66)

1. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
2. Cohen JJ: Apoptosis. Immunol Today 14:126, 1993
3. Osborne BA, Schwartz LM: Essential genes that regulate apoptosis. Trends Cell Biol 4:394, 1994
4. Steller H: Mechanisms and genes of cellular suicide. Science 267:1445, 1995
5. Golstein P, Ojcius DM. Young JD: Cell death mechanisms and the immune system. Immunol Rev 121:29, 1991
6. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
7. Bursch W. Oberhammer F, Schulte-Hermann R: Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13:245, 1992
8. Searle J, Lawson TA, Abbott PJ, Harmpn B, Kerr JFR: An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in population of proliferating normal and neoplastic cells. J Pathol 116:129, 1975
9. Arends MJ, Morris RG, Wyllie AH: Apoptosis. The role of endonuclease. Am J Pathol 136:593, 1990
10. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980
11. McDonald HR, Lees RK: Programmed death of autoreactive thymocytes. Nature 343:642, 1990
12. Dent AL, Matis LA, Hooshmand F, Widacki SM, Bluestone JA, Hedrick SM: Self-reactive gamma delta T cells are eliminated in the thymus. Nature 343:714, 1990
13. Jenkinson EJ, Kingston R, Smith CA, Williams GT, Owen JJ: Antigen-induced apoptosis in developing T cells: A mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol 19:2175, 1989
14. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181,1989
15. Cohen JJ, Duke RC: Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:38, 1984
16. Nieto MA, Lopez-Rivas A: IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J Immunol 143:4166, 1989
17. Migliorati G, Nicoletti I, Pagliacci MC, D'Adamio L, Riccardi C: Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81:1352, 1993
18. Nieto MA, Gonzalez A, Lopez-Rivas A, Diaz-Espada F, Gambon F: IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J Immunol 145:1364, 1990
19. Zacharchuk CM, Mercep M, Chakraborti PK, Simons SS Jr, Ashwell JD: Programmed T lymphocyte death. Cell activation-and steroid-induced pathways are mutually antagonistic. J Immunol 145:4037, 1990
20. Webb S, Morris C, Sprent J: Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 63:1249, 1990
21. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245, 1991
22. Kabelitz D, Pohl T. Pechhold K: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14:338, 1993
23. Dhein J, Walczak H, Bäumler C. Debatin KM, Krammer PH: Automne T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438,1995
24. Ju-ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
25. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
26. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
27. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
28. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995
29. Debatin KM, Goldmann CK, Bamford R, Waldmann TA, Krammer PH: Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia. Lancet 335:497, 1990
30. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in TCR transgenic mice. Immunity 1:365, 1994
31. +)-independent T cell-mediated cytotoxicity. J Exp Med 177:195, 1993
32. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
33. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182:1777, 1995
34. Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springher TA: The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 326:400, 1987
35. Moingeon P, Chang HC, Wallner BP, Stebbins C, Frey AZ, Reinherz EL: CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 339:312, 1989
36. Bierer BE, Peterson A, Gorga JC, Herrmann SH, Burakoff SJ: Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med 168:1145, 1988
37. Meuer SC, Hussey RE, Fabbri M, Fox D, Acuto O, Fritzgerald KA, Hodgon JC, Protentis IP, Schlossman SF, Reinherz EL: An alternative pathway of T cell activation: A functional role for the 50 kD T11 sheep erythrocyte receptor protein. Cell 36:897, 1984
38. Cerdan C, Martin Y, Courcoul M, Brailly H, Mawas C, Birg F, Olive D: Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol 149:2255, 1992
39. Linardopoulos S, Corrigall V, Panayi GS: Activation of HLA-DR and interleukin-6 gene transcription in resting T cells via the CD2 molecule: Relevance to chronic immune-mediated inflammation. Scand J Immunol 36:469, 1992
40. Sehajpal PK, Sharma VK, Ingulli E, Stenzel KH, Suthanthiran M: Synergism between the CD3 antigen-and CD2 antigen-derived signals. Exploration at the level of induction of DNA-binding proteins and characterization of the inhibitory activity of cyclosporine. Transplantation 55:1118, 1993
41. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS: Anti-CD2 receptor and anti-CD2 ligand (CD48) antibobodies synergize to prolong allograft survival. J Exp Med 179:341, 1994
42. Chavin KD, Qin L, Lin J, Woodward JE, Baliga P, Bromberg JS: Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-β production. Ann Surgery 218:492, 1993
43. Hirahara H, Tsuchida M, Watanabe T, Haga M, Matsumoto Y, Abo T, Eguchi S: Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 59:85, 1995
44. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 77:477, 1994
45. Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C: CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672, 1995
46. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271:521, 1996
47. Shimonkevitz R, Kappler J, Marrack P, Grey H: Antigen recognition by H-2-resctricted T cells. I. Cell-free antigen processing. J Exp Med 158:303, 1983
48. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR: Two types of mouse helper T-cell clone III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassay, and monoclonal antibodies. J Exp Med 166:1229, 1987
49. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
50. Nicoletti I, Migliorati G, Pagliacci C, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
51. Gavrieli Y, Sherman Y, Ben Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
52. Sander B, Höiden I, Andersson U, Möller E, Abrams JS: Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods 166:201, 1993
53. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806, 1995
54. Jones LA, Chin LT, Longo DL, Kruisbeek AM: Peripheral clonal elimination of functional T cells. Science 250:1726, 1990
55. Schwartz RH: A cell culture model for T lymphocytes clonal anergy. Science 248:1349, 1990
56. Steinman RM, Young JW: Signals arising from antigen-presenting cells. Curr Opin Immunol 3:361, 1991
57. + T cells from HIV-gp120-induced apoptosis. Eur J Immunol 25:2917, 1995
58. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
59. Yang Y, Mercep M, Ware CF, Ashwell JD: Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 181:1673, 1995
60. Janeway CA Jr: Ligands for the T-cell receptor: Hard times for avidity models. Immunol Today 16:223, 1995
61. Davis SJ, van der Merve PA: The structure and ligand interactions of CD2: Implication for T-cell function. Immunol Today 17:177, 1996
62. Ward SG, June CH, Olive D: P13-Kinase: A pivotal pathway in T-cell activation? Immunol Today 17:187, 1996
63. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348, 1995
64. Alien RD, Marshall JD, Roths JB, Sidman CL: Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172:1367, 1990
65. Gruss HJ, Dower SK: Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85:3378, 1995
66. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp 120. Nature 375:497, 1995